Table of Contents Table of Contents
Previous Page  18 / 21 Next Page
Information
Show Menu
Previous Page 18 / 21 Next Page
Page Background

THE GEC ESTROHANDBOOKOF BRACHYTHERAPY | Part I: The Basics of Brachytherapy

Version 1 - 22/10/2015

Radiobiology of LDR, HDR, PDR and VLDR Brachytherapy

18

12.

REFERENCES

1.

Ang KK, Van der Kogel AJ, Van der Schueren E. The kinetics of repair of sub-

lethal damage in the rat cervical spinal cord during fractionated irradiation.

Int J Radiat Oncol Biol Phys

1984; 11: 1977-83.

2.

Armour EP, White JR, Armin A,

et al

. Pulsed low dose rate BT in a rat model:

dependence of late rectal injury on radiation pulse size.

Int J Radiat Oncol Biol

Phys

1997; 38: 825-34.

3.

Awwad HK, Burgers MV. Studies in dose-time volume relationships in blad-

der and tongue radium implants.

Clin Radiol

1976; 27: 443-8.

4.

Bachtiary B, Dewitt A, Pintillie

et al

. Comparison of late toxicity between con-

tinuous low-dose-rat and pulsed-dose –rate BT in cervical cancer patients.

Int

J Radiat Oncol Biol Phys

2005; 63: 1077-82.

5.

Barendsen GW. Dose fractionation, dose rate and isoeffect relationships for

normal tissue responses.

Int J Radiat Oncol Biol Phys

1982; 8: 1981-7.

6.

7.

Barkley HY, Fletcher GH. Volume and time factor in interstitial gamma-ray

therapy.

Am J Roentgenol

1976; 126: 163-70.

8.

Bedford JS, Hall EJ. Threshold hypoxia: Ist effect on the survival of mammali-

an cells irradiated at high and low dose-rates.

Br J Radiol

1966; 39: 896-900.

9.

Benk V, Mazeron JJ, Grimard L,

et al

. Comparison of curietherapy versus ex-

ternal irradiation in Stage II squamous cell carcinoma of the mobile tongue.

Radiother Oncol

1990; 18: 339-47.

10. Bentzen SM, Thames HD. Clinical evidence for tumor clonogen regeneration:

interpretations of the data.

Radiother Oncol

1991; 22: 161-6.

11. Bentzen, S. M., Dörr, W., Gahbauer, R., Howell, R. W., Joiner, M. C., Jones, B.,

Jones, D. T. L., Van der Kogel, A. J., Wambersie, A., Whitmore, G. Bioeffect

modeling and equieffective dose concepts in radiation oncology Terminolo-

gy,quantities and units.

Radiother. Oncol

., 2012 105, 266-268

12. Brenner DJ, Hall EJ. Fractionated high dose rate versus low dose rate regimens

for intracavitary technique of the cervix.

Br J Radiol

1991; 64: 133-41.

13. Brenner DJ, Hall EJ. Conditions for the equivalence of continuous to pulsed

low dose rate BT.

Int J Radiat Oncol Biol Phys

1991; 20: 181-90.

14. Brenner DJ, Hall EJ, Huang Y, Sachs RK. Potential reduced late effects for

pulsed BT compared with conventional LDR.

Int J Radiat Oncol Biol Phys

1995; 31: 201-10.

15. Brenner DJ, Schiff PB, Huang Y, Hall EJ. Pulsed-dose-rate BT: design of con-

venient (day-time only) schedules.

Int J Radiat Oncol Biol Phys

1997; 39: 809-

15.

16. Bruna A, Gastelblum P, Thomas L

et al

. treatment of squamous cell anal canal

carcinoma (SCACC) with pulsed dose rate BT: a retrospective study.

Radioth

Oncol

2006; 79: 75-79.

17. Cosset JM, Henry-Amar M,Girinsky T

et al

. late toxicity of radiotherapy in

Hodgkin’s disease: the role of fraction size.

Acta Oncol

1988; 27: 123 – 46

18. Cha C. M., Potters L., Ashley R., Freeman K., Wang X.-H., Waldbaum R.,Liebe

S. l, ‘‘Isotope selection for patients undergoing prostatebrachytherapy,’’

Int. J.

Radiat. Oncol, Biol., Phys.

45, 31–395 ~1999.

19. Dale RG. The applications of the linear-quadratic dose effect equation to frac-

tionated and protracted therapy.

Br J Radiol

1985; 58: 515-28.

20. Dale RG. Radiobiological assessment of permanent implants using tumour

repopulation factors in the linear-quadratic model.

Br J Radiol

1989; 62: 241-4.

21. Dale RG, Jones B, Coles IP. Effect of tumour shrinkage on the biological effec-

tiveness of permanent BT implants.

Br J Radiol

1994; 67: 639-45.

22. De Pree C, Popowski Y,Weber D.Nouet P, Rouzaud M, Kurtz JM. Feasibility

and tolerance of pulsed dose rate interstitial BT.

Int J Radiat Oncol Biol Phys

1999; 43: 971-6.

23. Donath D, Vuong T, Shenouda G, MacDonald B, Tabah R. The potential uses

of high-dose-rate brachytherapy in patients with head and neck cancer.

Eur

Arch Otorhinolaryngol.

1995;252:321–324.

24. Dörr,W.,Van der Kogel,A.J.The volume effect in radiotherapy in: Joiner, M.,

Van der Kogel, A. (Eds.)

Basic Clinical Radiobiology,

4th Edition, Chapter 14;

Hodder Arnold, London, 2009; 191-206

25. Dörr,W. :Time factors in normal tissue responses to irradiation in: Joiner, M.,

Van der Kogel, A. (Eds.)

Basic Clinical Radiobiology,

4th Edition, Chapter 11;

Hodder Arnold, London, 2009, 149-157

26. Dörr, W.Modulation of repopulation processes in oral mucosa: experimental

results

Int. J. Radiat. Biol.

79, 2003, 531-537

27. Dörr, W.Three A’s of repopulation during fractionated irradiation in squa-

mous epithelia: Asymmetry loss, Acceleration of stem-cell divisions and abor-

tivedivisions.

Int. J. Radiat. Biol.

72, 1997, 635-643

28. Dörr,W.The radiobiology of tissue reactions

Ann. ICRP

44, 1 Suppl., 2015, 58-

68

29. Dörr,W.,Schmidt,M.:Normal tissue radiobiology In: Brahme, A. (Ed.-in-

Chief), Hendry, J. H. (Vol. Ed.): Comprehensive biomedical physics. Vol. 7,

Chapter 7.05, Elsevier, Amsterdam-Oxford-Waltham, 2014, 75-95

30. Dubray B, Mazeron JJ, Simon JM,

et al

. Time factors in breast carcinoma:

influence of delay between external irradiation and radiotherapy.

Radiother

Oncol

1992; 25: 267-72.

31. Finestres-Zubeldia F, Guix Melcior B, Cloquell Damián A,

et al

. Treatment of

the carcinoma of the lip through high dose rate BT.

Med Oral Patol Oral Cir

Bucal

2005; 10: 17-24

32. Fontanesi MD, Hetzler D, Ross J. Effects of dose rate on local control and com-

plications in the re-irradiation of the head and neck tumors.

Int J Radiat Oncol

Biol Phys

1989; b: 365-9.

33. Fourquet A, Campana F, Mosseri V,

et al

. Iridium

-192

versus cobalt

-60

boost in

breast treated by irradiation alone: final results of a randomized trial.

Radioth-

er Oncol

1995; 34: 114-20.

34. Fowler JF, Toma-Dasu I, Dasu A Is the α/β ratio for prostate tumours really

low and does it vary with the level of risk at diagnosis?

Anticancer Res.

2013

Mar;33(3):1009-11

35. Fowler JF, Mount M. Pulsed BT: the conditions for no significant loss of ther-

apeutic ratio compared with traditional low dose rate BT.

Int J Radiat Oncol

Biol Phys

1992; 23: 661-9.

36. Fowler JF. Why shorter half-times of repair lead to greater damage in pulsed

BT.

Int J Radiat Oncol Biol Phys

1993; 26: 353-56.

37. Fowler JF. Are half-times of repair reliably shorter for tumors than for late

normal-tissue effects?

Int J Radiat Oncol Biol Phys

1995; 31: 189-90.

38. Fowler JF, Van Limbergen E. Biological effect of pulsed dose rate BT with step-

ping sources if short half-times of repair are present in tissues.

Int J Radiat

Oncol Biol Phys

1997; 37: 877-83.

39. Fritz P, Berns C, Anton HW

et al

. PDR BT with flexible implants for intestinal

boost after breast-conserving surgery and external beam radiation therapy.

Radiother Oncol

1997; 45: 23-32.

40. Fritz P, Hensley FW, Berns C

et al

. Long-term results of pulsed irradiation

of skin metastases from breast cancer. Effectiveness and sequel.

Strahlenther

Onkol

2000; 176: 368-376.

41. Fu KK, Phillips TL. High-dose-rate versus low-dose-rate intracavitary

brachytherapy for carcinoma of the cervix.

Int J Radiat Oncol Biol Phys.

1990;

19(3):791-6.

42. Fu KK, Chan EK, Phillips TL, Ray JW. Time, dose and volume factors in inter-

stitial radium implants of the oral tongue.

Radiology

1976; 119: 209-13.

43. Galalae RM, Martinez A, Mate T,

et al

. Long-term outcome by risk factors us-

ing conformal high-dose-rate brachytherapy (HDR-BT) boost with or without

neoadjuvant androgen suppression for localized prostate cancer

Int J Radiat

Oncol Biol Phys. 2

004 Mar 15;58(4):1048-55

44. Gérard JP, Mauro F, Thomas L, Castelain B ,Mazeron JJ, Ardiet JM,Peiffert

D. Treatment of squamous cell anal canal carcinoma with pulsed dose rate

BT. Feasibility study of a French Cooperative group.

Radiother Oncol

1999;

51:129-31.

45. Girinsky T, Rey A, Roche B, Haie C, Gerbaulet A, Randrianarivello H, Chas-

sagne D.Overall treatment time in advanced cervical carcinomas: a critical

parameter in treatment outcome.

Int J Radiat Oncol Biol Phys.

1993 Dec 1;

27(5):1051-6.

46. Guinot JL, Arribas L, Chus ML,

et al

. Lip cancer treatment with high dose rate

BT.

Radioth Onocl

2003; 69:113-115

47. Haie-Meder C, Kramar A, Lambin P,

et al

. Analysis of complications in a pro-